From the Department of Pathology, University of Mississippi Medical Center, Jackson. Dr King is now with the Department of Pathology, Baylor Scott & White Medical Center/Texas A&M College of Medicine Health Science Center, Temple.
Arch Pathol Lab Med. 2020 Feb;144(2):160-167. doi: 10.5858/arpa.2019-0182-RA.
CONTEXT.—: Large B-cell lymphomas represent the most common non-Hodgkin lymphomas and often present as extranodal masses with advanced stage similar to metastatic tumors. Without proper intraoperative, microscopic, immunophenotypic, and cytogenetic evaluation they may be mistaken for other hematopoietic or even nonhematopoietic tumors. Also, diffuse large B-cell lymphomas often have clinical, morphologic, immunophenotypic, and cytogenetic clinical features that are similar to those of other less common B-cell lymphomas. Furthermore, classification of these neoplasms is continually becoming more refined.
OBJECTIVE.—: To provide a rational, methodic approach to the evaluation of large B-cell lymphomas for community practice pathologists who provide general pathology services.
DATA SOURCES.—: This review incorporates guidelines detailed in the 2017 update to the World Health Organization's in addition to other recent peer-reviewed publications.
CONCLUSIONS.—: Many large B-cell neoplasms respond favorably to current treatments, but these cases also require accurate and timely diagnoses. We propose a process following a brief checklist that focuses on diffuse large B-cell lymphoma, the most common entity, and rules out other similar lymphomas in a stepwise fashion.
大 B 细胞淋巴瘤是最常见的非霍奇金淋巴瘤,常表现为晚期的结外肿块,类似于转移性肿瘤。如果没有适当的术中、显微镜下、免疫表型和细胞遗传学评估,它们可能被误诊为其他造血系统甚至非造血系统肿瘤。此外,弥漫性大 B 细胞淋巴瘤在临床上、形态学上、免疫表型上和细胞遗传学上的特征与其他不太常见的 B 细胞淋巴瘤相似。此外,这些肿瘤的分类不断得到细化。
为提供一种合理、系统的方法来评估社区实践病理学家提供的大 B 细胞淋巴瘤,这些病理学家提供一般病理学服务。
本综述纳入了 2017 年世界卫生组织更新的指南,以及其他最近的同行评议出版物中的详细信息。
许多大 B 细胞肿瘤对目前的治疗反应良好,但这些病例也需要准确和及时的诊断。我们提出了一个简短的检查表后的过程,重点关注最常见的实体,即弥漫性大 B 细胞淋巴瘤,并以逐步的方式排除其他类似的淋巴瘤。